Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Active — Not RecruitingPhase 3

NCT03091660

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

This randomized phase III trial studies Tokyo-172 strain bacillus Calmette-Guerin (BCG) solution with or without a vaccination using Tokyo-172 strain BCG to see…

United States1,000 participantsStarted 2017-02-24

Treatment: BCG Solution, BCG Tokyo-172 Strain Solution

WithdrawnPhase 1

NCT03430687

Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma

This phase I trial studies the side effects and best dose of talimogene laherparepvec and to see how well it works in treating patients with non-muscle invasive…

United States0Started 2018-06-01

Treatment: Laboratory Biomarker Analysis, Talimogene Laherparepvec